Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines — Stella

Recruiting

Back to Poliomyelitis trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

Bangladesh

International Centre for Diarrhoeal Disease Research, Dhaka

International Centre for Diarrhoeal Disease Research, Dhaka

Key details

Phase

Early testing / Safety & dosing

Sponsor

PATH

Collaborators

Bio Farma, Indonesia

Enrollment target

~2,400 participants

Started

November 2024

Primary completion

December 2027

Age range

0 Days – 45 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov